Status:
COMPLETED
Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone
Lead Sponsor:
Bayer
Conditions:
Hypogonadism
Eligibility:
MALE
18+ years
Brief Summary
We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resultin...
Eligibility Criteria
Inclusion
- \- All male individuals in the source population with a first testosterone use during the study period will be included as cases. The date of the GP consultation associated with the first testosterone prescription will be designated as the index day.
Exclusion
- \- Patients of less than 18 years on the index day, with less than 2-year contribution to the CPRD-HES link before the index day, or with use of testosterone before the study period will be excluded from the group of cases.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2018
Estimated Enrollment :
27778 Patients enrolled
Trial Details
Trial ID
NCT03484260
Start Date
April 1 2018
End Date
May 15 2018
Last Update
May 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations
Berlin, Germany, 13342